The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Decreased copy number aberrations in genomes of HER2+ metastatic breast cancer (MBC) patients (pts) with extraordinary durable complete responses (dCR) to trastuzumab (T).
 
Alanna Maguire
No Relationships to Disclose
 
Giuseppe Gullo
No Relationships to Disclose
 
Cecily Quinn
No Relationships to Disclose
 
Smriti Malasi
Employment - Caris Life Sciences
 
Elizabeth Lenkiewicz
No Relationships to Disclose
 
Michael T. Barrett
No Relationships to Disclose
 
Norma O'Donovan
Research Funding - Boehringer Ingelheim (I); Eisai (I); GlaxoSmithKline (Inst); Novartis (Inst)
 
Naomi Walsh
No Relationships to Disclose
 
John Crown
Honoraria - Bayer; Eisai; Genomic Health; New Oncology; Novartis; Pfizer; Teva
Consulting or Advisory Role - Bayer; Eisai; Genomic Health; New Oncology; Novartis; Pfizer; Teva
Speakers' Bureau - Genomic Health; Pfizer
Research Funding - Boehringer Ingelheim (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Roche (Inst)